gabexate has been researched along with Lymphoma in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniguchi, N | 1 |
| Kitani, T | 1 |
| Kawagoe, H | 1 |
| Horiuchi, A | 1 |
| Masaoka, T | 1 |
| Yasunaga, K | 1 |
| Okamoto, Y | 1 |
| Ohkubo, A | 1 |
| Yonezawa, T | 1 |
| Nagai, K | 1 |
1 other study available for gabexate and Lymphoma
| Article | Year |
|---|---|
[Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Topics: Aged; Aged, 80 and over; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Fe | 1987 |